Accueil > articulos > Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model > BibTeX |
@article{Rodrigo:107335, author = "Rodrigo, M.J. and Cardiel, M.J. and Fraile, J.M. and Mendez-Martinez, S. and Martinez-Rincon, T. and Subias, M. and Polo, V. and Ruberte, J. and Ramirez, T. and Vispe, E. and Luna, C. and Mayoral, J.A. and Garcia-Martin, E.", title = "{Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model}", year = "2020", }